FDA Inspection Growth In China Stymied By Visa Issues
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency is waiting for approval to locate 10 new drug inspectors in China.
You may also be interested in...
FDA Talks Drug Safety With China, But Visas Still Elusive For Staff
The agency is unable to place more inspectors in China even as Howard Sklamberg, deputy commissioner for global regulatory operations and policy, visits Beijing.
FDA Talks Drug Safety With China, But Visas Still Elusive For Staff
The agency is unable to place more inspectors in China even as Howard Sklamberg, deputy commissioner for global regulatory operations and policy, visits Beijing.
FDA Talks Drug Safety With China, But Visas For Staff Still Elusive
Agency unable to place more inspectors in China even as Howard Sklamberg visits Beijing.